Trials / Completed
CompletedNCT04486794
Restylane® for the Treatment of Tear Trough Deformity
A Clinical Evaluation of the Efficacy and Safety of Hyaluronic Acid (Restylane®) for the Treatment of Tear Trough Deformity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Erevna Innovations Inc. · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate the effectiveness and tolerability of Restylane® for correction of tear trough deformity, using various injection techniques.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane® | Hyaluronic acid |
Timeline
- Start date
- 2019-07-07
- Primary completion
- 2020-12-30
- Completion
- 2020-12-31
- First posted
- 2020-07-27
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04486794. Inclusion in this directory is not an endorsement.